H. Pylori and SIBO: Low Stomach Acid, Gastritis & Hypochlorhydria

Gastric acid acts as the body’s primary chemical gatekeeper, sterilizing ingested food upon entry and preventing microbial colonization downstream. When Helicobacter pylori infects the gastric mucosa, it systematically dismantles this frontline defense. Although H. pylori resides in the stomach while small intestinal bacterial overgrowth (SIBO) develops in the mid-gut, the two disorders are biologically intertwined. By neutralizing stomach acid to ensure its own survival, H. pylori removes the chemical barrier that normally prevents colonic bacteria from colonizing the small intestine.

Understanding how these two conditions interact requires looking at the digestive system as a single connected continuum. An infection in the stomach changes the environment of the small intestine. The connection between Helicobacter pylori and Small Intestinal Bacterial Overgrowth involves changes to stomach acid, the disruption of digestive hormones, a breakdown in gut movement, shared nutrient deficiencies, and overlapping diagnostic test results.

The Digestive Environment and Bacterial Defenses

The stomach and the small intestine are neighboring organs, but they have very different environments. The stomach is highly acidic. This acid has two main purposes. First, it begins the process of breaking down food, particularly proteins. Second, it is a chemical barrier that protects the rest of the digestive tract from outside invaders. Most bacteria that enter the body through food or water cannot survive the extreme acidity of a healthy stomach¹.

The small intestine is the next section of the digestive tract. It is a long, winding tube where the body absorbs most of its nutrients. In a healthy person, the small intestine contains relatively few bacteria compared to the large intestine. The normal bacterial count in the small intestine is kept low by several built-in defense mechanisms. The primary defense mechanism is the flow of strong stomach acid coming down from the stomach¹.

When the stomach acid barrier fails, the small intestine becomes vulnerable. Bacteria from the mouth, throat, and food survive the journey through the stomach and settle in the small intestine. At the same time, bacteria from the large intestine travel upward and build colonies in the small intestine. When the number of bacteria in the small intestine exceeds normal limits, the condition is diagnosed as Small Intestinal Bacterial Overgrowth¹, a microbial breakdown detailed in our guide to what is SIBO.

The Stomach Acid Connection

The most significant link between Helicobacter pylori and Small Intestinal Bacterial Overgrowth is stomach acid. A healthy stomach maintains a pH level between 1.5 and 3.02. The pH scale measures how acidic or alkaline a liquid is, with lower numbers indicating higher acidity. A pH between 1.5 and 3.0 creates an extremely harsh environment, which is necessary to kill bacteria on ingested food².

Helicobacter pylori is one of the few organisms capable of surviving in this extreme environment. It survives by using a specific chemical defense mechanism. The bacteria produce an enzyme called urease². Urease takes urea, a natural substance found in stomach fluids, and converts it into ammonia and carbon dioxide². Ammonia is a strong base, meaning it is highly alkaline. When Helicobacter pylori produces ammonia, the ammonia neutralizes the stomach acid in the immediate area around the bacteria². This creates a protective alkaline bubble that allows the bacteria to live and multiply safely inside the mucus layer of the stomach lining².

Over time, this localized acid neutralization leads to widespread changes. The constant presence of Helicobacter pylori triggers a chronic immune response. The body attempts to fight the infection, resulting in long-term inflammation of the stomach lining². After years or decades of chronic inflammation, the specialized cells in the stomach that produce stomach acid, known as parietal cells, become damaged and die off. This progressive damage is called atrophic gastritis².

As the parietal cells disappear, the stomach loses its ability to produce adequate amounts of hydrochloric acid. This condition is called hypochlorhydria, or low stomach acid¹. In severe cases, the stomach stops producing acid entirely, a state known as achlorhydria².

Hypochlorhydria connects a stomach infection directly to an intestinal overgrowth. When stomach acid levels drop, the pH of the stomach rises above 3.5 or 4.03. At this higher pH level, the stomach can no longer effectively kill bacteria². Organisms that would normally die on contact survive the passage through the stomach. These bacteria travel directly into the small intestine. Because the small intestine is warm, dark, and full of partially digested food, it provides an ideal environment for these surviving bacteria to multiply. This sequence of events explains why low stomach acid caused by Helicobacter pylori is one of the primary underlying causes of SIBO¹.

Observational studies and meta-analyses confirm this relationship through statistical data. In studies involving hundreds of patients, an active Helicobacter pylori infection increases the odds of having Small Intestinal Bacterial Overgrowth by a ratio of 1.8211. The association is even more pronounced in younger patients under the age of 48. In this age group, a stomach infection increases the odds of an intestinal overgrowth by a ratio of 2.6811. Patients with an active Helicobacter pylori infection have a much higher occurrence rate of Small Intestinal Bacterial Overgrowth compared to uninfected individuals, with rates measuring around 60.4% in infected groups versus 30.6% in uninfected groups⁶.

Disruption of Digestive Hormones and Enzymes

The effects of low stomach acid extend beyond the loss of the bacterial barrier. Stomach acid acts as a chemical trigger for the rest of the digestive process. When food leaves the stomach and enters the first part of the small intestine, called the duodenum, the high acidity of the food mixture signals the release of specific digestive hormones.

The two most important hormones in this process are secretin and cholecystokinin⁵. Secretin signals the pancreas to release bicarbonate and digestive enzymes¹⁵. Bicarbonate is an alkaline substance that neutralizes the stomach acid once it enters the small intestine, preventing the acid from burning the intestinal lining¹⁵. Cholecystokinin signals the gallbladder to contract and release bile into the small intestine¹⁶. Bile is a digestive fluid produced by the liver that breaks down dietary fats¹⁷.

When a person has Helicobacter pylori and develops low stomach acid, this entire hormonal signaling system breaks down. Because the food mixture leaving the stomach is not acidic enough, the small intestine does not release adequate amounts of secretin or cholecystokinin⁵. Without these hormonal signals, the pancreas does not release enough digestive enzymes, and the gallbladder does not release enough bile¹⁴.

This lack of bile and pancreatic enzymes directly contributes to Small Intestinal Bacterial Overgrowth. Digestive enzymes and bile are required to break carbohydrates, proteins, and fats into tiny, absorbable molecules. When these enzymes are missing, large amounts of food remain undigested as they move through the small intestine. This undigested food becomes a primary food source for the bacteria living in the small intestine³.

The bacteria consume these undigested carbohydrates and ferment them. Fermentation is a chemical process where bacteria break down sugars and produce gases as a byproduct. In the small intestine, this fermentation process produces large volumes of hydrogen, methane, and carbon dioxide gases⁴. These trapped gases cause the severe bloating, abdominal pain, distension, and flatulence that characterize Small Intestinal Bacterial Overgrowth¹. Furthermore, bile has natural antimicrobial properties that help control bacterial populations in the small intestine. When bile secretion is reduced due to low stomach acid, this secondary chemical defense against bacterial overgrowth is lost⁴.

Gut Motility and the Migrating Motor Complex

Coordinated muscular contractions push food, cellular waste, and bacteria forward through the intestinal tube. The failure of these peristaltic movements is another critical factor connecting Helicobacter pylori to Small Intestinal Bacterial Overgrowth.

Between meals, when a person is fasting, the digestive system initiates a specific pattern of muscle contractions called the migrating motor complex (MMC)⁴. The migrating motor complex acts as an internal cleaning wave⁸. Approximately every 90 to 120 minutes during periods of fasting, a strong wave of muscle contractions sweeps through the stomach and the small intestine⁴. The purpose of this wave is to clear out leftover food particles, digestive fluids, and excess bacteria, pushing them firmly into the large intestine where they belong⁴.

When the migrating motor complex is functioning properly, bacteria cannot easily colonize the small intestine because they are constantly being swept away. Small Intestinal Bacterial Overgrowth occurs when this sweeping mechanism is disrupted or slowed down⁴. If the waves are too weak or happen too infrequently, bacteria have the time to attach to the intestinal walls and multiply⁴.

Research indicates that Helicobacter pylori infections are associated with altered gastric emptying and disrupted gut motility⁸. Gastric emptying refers to the speed at which the stomach empties its contents into the small intestine. Helicobacter pylori causes a delay in this process, a condition sometimes referred to as gastroparesis or delayed stomach emptying¹⁰. When the stomach empties too slowly, it disrupts the timing and the strength of the migrating motor complex¹⁰.

The connection between the stomach infection and the migrating motor complex involves the vagus nerve. The vagus nerve is a major nerve that runs from the brain down into the abdomen, controlling the involuntary muscles of the digestive tract. It is responsible for starting the secretion of stomach acid and controlling the rhythm of the migrating motor complex¹⁹. Patients with Helicobacter pylori infections often show signs of reduced vagus nerve activity²⁰. When the vagus nerve is underactive, the stomach produces less acid, and the migrating motor complex becomes sluggish¹⁹. This sluggish movement provides the exact conditions necessary for bacteria to accumulate and overgrow in the small intestine.

Methane and Intestinal Methanogen Overgrowth

Small Intestinal Bacterial Overgrowth is grouped into different subtypes based on the type of gases the organisms produce. The organisms in the small intestine produce hydrogen, methane, or hydrogen sulfide²¹.

Medical research has shown that methane-dominant overgrowth is caused by a different type of organism. The organisms that produce methane are not bacteria. They belong to a distinct biological category called archaea²². The most common archaea found in the human gut is Methanobrevibacter smithii²². Because these organisms are not bacteria, methane-dominant Small Intestinal Bacterial Overgrowth is now more accurately referred to as Intestinal Methanogen Overgrowth²².

There is a distinct link between Helicobacter pylori and the presence of methane-producing archaea in the gut. Clinical studies analyzing breath test results show that patients infected with Helicobacter pylori are more likely to produce high levels of methane gas compared to uninfected patients²⁴. In studies using lactulose breath tests, the production of methane gas was observed at a much higher frequency in patients who tested positive for a stomach infection²⁴.

The archaea that produce methane survive by consuming hydrogen gas, which is produced by other fermenting bacteria in the small intestine²². The methane gas they generate has a localized effect on the muscles of the digestive tract. Methane gas acts as a paralytic agent on intestinal smooth muscle. It slows down the rhythmic contractions of the gut, increasing the time it takes for food and waste to travel through the colon²².

This creates a self-perpetuating cycle. Helicobacter pylori lowers stomach acid and impairs the vagus nerve, which slows down the migrating motor complex. The slowed motility allows bacteria and archaea to accumulate. The archaea produce methane gas, which then paralyzes the intestinal muscles and slows down gut motility even more²². The physical result of this methane production is severe constipation, which is a common symptom of Intestinal Methanogen Overgrowth²¹. By slowing the transit time, the methane ensures that the organisms have a constant supply of food and are not flushed out of the small intestine²².

Shared Nutrient Deficiencies

Because Helicobacter pylori and Small Intestinal Bacterial Overgrowth both damage the normal digestive process, they share a very similar profile of nutrient deficiencies. Patients dealing with either condition frequently suffer from a lack of iron, vitamin B12, and fat-soluble vitamins, which can be evaluated through targeted blood tests. The steps behind these deficiencies show how deeply interconnected the two conditions are.

Iron deficiency is a frequent complication. Iron from plant foods, known as non-heme iron, enters the stomach in a ferric state. To be absorbed by the small intestine, this iron must be converted into a ferrous state. Strong stomach acid is required to trigger this chemical conversion². When Helicobacter pylori reduces stomach acid through localized ammonia production and chronic gastritis, the body cannot convert ferric iron to ferrous iron. The iron passes unabsorbed through the small intestine, leading to iron-deficiency anemia².

Vitamin B12 deficiency operates through a similar process. Vitamin B12 in food is tightly attached to animal proteins. When food reaches the stomach, strong stomach acid and an enzyme called pepsin are required to break the protein apart and release the vitamin B12². Without sufficient stomach acid due to a Helicobacter pylori infection, the vitamin B12 remains trapped inside the food protein and cannot be absorbed².

Additionally, the same parietal cells in the stomach that produce acid also produce a special protein called intrinsic factor². Intrinsic factor is completely necessary for the absorption of vitamin B12 later in the digestive tract². When Helicobacter pylori destroys the parietal cells, the stomach stops producing both acid and intrinsic factor.

Even if some vitamin B12 is released and attached to intrinsic factor, Small Intestinal Bacterial Overgrowth presents another obstacle. The excessive bacteria in the small intestine actively consume vitamin B12⁹. They intercept the nutrient as it travels through the digestive tract, leaving the human host deficient²¹. This lack of B12 causes fatigue, weakness, and long-term neurological symptoms⁹.

The connection between the two conditions also affects the absorption of fats and fat-soluble vitamins, which include vitamins A, D, E, and K¹. Low stomach acid prevents the proper release of bile from the gallbladder. Bile is required to break dietary fats down into microscopic droplets that can be absorbed by the intestinal lining¹⁷.

When Small Intestinal Bacterial Overgrowth is present, the bacteria interact with whatever small amount of bile does reach the small intestine. Certain bacteria in the overgrowth possess enzymes that alter the chemical structure of the bile acids. This process is called bile acid deconjugation²⁵. Deconjugated bile acids are completely ineffective at breaking down fats²⁶. Because the fats are not broken down, the fat-soluble vitamins trapped inside them cannot be accessed. The undigested fats pass through the digestive tract, leading to a condition called steatorrhea, or fatty diarrhea, and causing a loss of vitamins A, D, E, and K¹.

Diagnostic Overlaps and Testing Challenges

Diagnosing these two conditions is complicated by the fact that they can interfere with each other’s diagnostic tests.

To diagnose a stomach infection, medical professionals use the Urea Breath Test⁷. The patient drinks a liquid solution containing urea that has been marked with a specific carbon tag. If Helicobacter pylori is present in the stomach, its urease enzyme breaks down the urea into ammonia and carbon dioxide. The carbon dioxide, containing the specific tag, is absorbed into the bloodstream, travels to the lungs, and is exhaled. The test measures the amount of this specific carbon dioxide in the patient’s breath⁷.

To diagnose an overgrowth in the small intestine, medical professionals use a Glucose or Lactulose Breath Test²¹. The patient drinks a solution of sugar. As the sugar travels into the small intestine, the overgrowing bacteria consume it and ferment it. This fermentation produces hydrogen and methane gases. These gases are absorbed into the bloodstream, travel to the lungs, and are exhaled. The test measures the levels of hydrogen and methane over a period of two to three hours²¹.

The diagnostic confusion occurs because Helicobacter pylori is not the only organism capable of producing the urease enzyme¹. Several types of bacteria that commonly overgrow in the small intestine are also urease-positive¹. If a patient has severe Small Intestinal Bacterial Overgrowth, they have large populations of these urease-producing bacteria living just below the stomach.

When this patient takes a Urea Breath Test, the urea solution passes through the stomach and enters the small intestine. The overgrowing bacteria in the small intestine immediately break down the urea and produce the carbon dioxide tag. The patient exhales the gas, and the test registers as positive. The doctor may diagnose the patient with a Helicobacter pylori infection, when in reality, the stomach is clear. The positive result was entirely caused by the bacteria in the small intestine reacting to the test¹. Bacterial overgrowth causes a false-positive Helicobacter pylori diagnosis using urea-based testing¹.

Researchers analyzing fluid directly from the small intestine, a process called a duodenal aspirate culture via upper endoscopy, have found a strong correlation between the two conditions. Duodenal aspirate culture is a highly accurate way to diagnose an overgrowth, as it involves inserting a tube down the throat and physically extracting fluid from the small intestine to count the bacterial colonies³⁰. Studies utilizing this method demonstrate that patients with confirmed Helicobacter pylori infections show significantly higher bacterial colony counts in their small intestine fluid compared to uninfected individuals³².

Treatment Intersections and the Role of Medications

The medications used to treat a stomach infection often act as the direct cause of an intestinal overgrowth. Eradicating Helicobacter pylori requires a multi-drug plan, typically involving two different antibiotics and a proton pump inhibitor⁶.

Proton pump inhibitors are medications that chemically block the parietal cells in the stomach from secreting hydrochloric acid¹⁵. In the context of treating an infection, the proton pump inhibitor serves to lower the acidity of the stomach. This allows the antibiotics to work more effectively and gives the damaged stomach lining a chance to heal⁶.

However, suppressing stomach acid with medication creates the exact environment that causes Small Intestinal Bacterial Overgrowth⁶. While the medication is actively suppressing the acid, the stomach loses its ability to kill bacteria on ingested food. In healthy patients taking a standard 20-milligram dose of a proton pump inhibitor, the stomach pH rises by approximately two points⁶. In patients who already have an active Helicobacter pylori infection, taking the exact same dose causes the stomach pH to rise by four points, pushing the environment into a highly alkaline state of 5.0 to 6.06.

Within this elevated, non-acidic pH range, the bacterial load entering the small intestine increases by a thousand-fold⁶. Because the patient is also taking antibiotics at the same time, the natural balance of the intestinal bacteria is disrupted, a state known as dysbiosis⁶. The combination of a compromised acid barrier and an antibiotic-disrupted gut creates a perfect window for gas-producing bacteria to colonize the small intestine. Meta-analyses of clinical studies identify proton pump inhibitor therapy as a significant risk factor for developing Small Intestinal Bacterial Overgrowth¹³. In studies using duodenal aspirate cultures, proton pump inhibitor use was associated with an increased odds ratio of 7.587 for developing an overgrowth³⁴.

This treatment problem affects patients trying to cure their intestinal overgrowth while unknowingly harboring a stomach infection. Small Intestinal Bacterial Overgrowth is difficult to permanently cure, with high rates of relapse within months of finishing an antibiotic treatment⁴. When a patient experiences constant relapse, it indicates that the underlying cause in the digestive system has not been resolved⁴.

If a patient undergoes treatment for Small Intestinal Bacterial Overgrowth but has an undiagnosed Helicobacter pylori infection, the stomach acid barrier remains broken, and the migrating motor complex remains slow⁴. The antibiotics clear the bacteria from the small intestine temporarily, providing a few weeks of symptom relief. However, as soon as the patient stops the antibiotics, the constant stream of live bacteria flowing from the low-acid stomach repopulates the small intestine². Resolving persistent Small Intestinal Bacterial Overgrowth requires first identifying and eradicating any underlying Helicobacter pylori infection⁸.

Clinical observations support this cause-and-effect relationship. In studies where patients were diagnosed with both conditions, treating and eradicating the Helicobacter pylori infection resulted in a spontaneous reduction in the rates of Small Intestinal Bacterial Overgrowth. Following eradication therapy, the prevalence of the overgrowth dropped significantly from 60.4% down to 20.8%¹³. When the stomach infection is cured, the stomach lining slowly recovers its ability to produce acid, the chemical barrier is restored, and the small intestine is once again protected from invasive bacteria¹³.

Systemic Inflammation and Shared Symptoms

The physical symptoms of both conditions overlap heavily. Both conditions generate a baseline of chronic inflammation that alters how the digestive tract functions.

When Helicobacter pylori infects the stomach, it brings inflammatory immune cells to the stomach lining². When bacteria overgrow in the small intestine, they release toxic byproducts called lipopolysaccharides³⁷. These toxins trigger the immune system, resulting in a state of chronic inflammation along the entire intestinal wall¹. Studies analyzing duodenal aspirates in patients with Small Intestinal Bacterial Overgrowth show elevated levels of specific inflammatory markers, including interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha⁴¹.

This chronic inflammation causes a breakdown in the physical structure of the intestinal lining, a condition commonly referred to as increased intestinal permeability, or leaky gut³. The intestinal wall acts as a tight filter, only allowing fully digested nutrients to pass into the bloodstream. When the wall becomes inflamed and permeable, larger, undigested food proteins and bacterial toxins slip through the barrier and enter the bloodstream³.

The presence of these foreign molecules in the bloodstream provokes a wide range of immune responses throughout the body. This explains why both conditions are frequently associated with extra-intestinal symptoms, which are symptoms that occur outside of the digestive tract. Patients with either condition frequently report severe brain fog, systemic fatigue, joint pain, and mood swings³.

There is also a documented link between both conditions and inflammatory skin disorders. Clinical studies evaluate the rates of both bacterial issues in patients suffering from rosacea, a chronic inflammatory skin condition characterized by facial redness. Research demonstrates that a significant proportion of patients with rosacea test positive for either Helicobacter pylori or Small Intestinal Bacterial Overgrowth⁴². When researchers account for overlapping variables, the data suggests that the systemic inflammation originating from the compromised gut barrier shows up physically in the skin⁴².

Within the digestive tract itself, the physical symptoms are nearly identical. Both conditions cause upper abdominal discomfort, nausea, chronic bloating, burping, and altered bowel habits¹, matching the hallmark SIBO symptoms. However, certain specific symptoms lean slightly more toward one condition than the other. Symptoms that occur immediately upon eating, such as early fullness, stomach pain, and frequent belching, are more closely tied to the localized stomach inflammation of Helicobacter pylori⁸. Symptoms that occur an hour or two after eating, such as severe lower abdominal distension, trapped gas, and extreme shifts between diarrhea and constipation, are more indicative of the fermentation process happening lower down in the small intestine⁸.

Comparing the Two Conditions

To clarify how these two conditions interact, it is helpful to look at a direct comparison of their mechanics, locations, and effects on the body. While they are linked by cause and effect, they are distinctly different types of bacterial problems.

Helicobacter pylori is a specific, singular species of bacteria. It is an outside pathogen that enters the body and colonizes a location where it does not belong. Its primary survival mechanism is chemical adaptation, which involves neutralizing the acid around it to survive.

Small Intestinal Bacterial Overgrowth is not a specific species of bacteria. It is a general term describing a condition where normal bacteria that safely exist in the large intestine move into the wrong anatomical location. It is a problem of volume and location rather than a specific infectious agent. The primary mechanism of causing symptoms is not an infection of the tissue, but rather the fermentation of human food sources.

Feature	Helicobacter pylori Infection	Small Intestinal Bacterial Overgrowth (SIBO)
Primary Location	The stomach².	The small intestine (duodenum and jejunum)¹.
Type of Organism	A single, specific bacterial pathogen (Helicobacter pylori)².	A mix of normal colon bacteria or archaea in the wrong location⁴.
Mechanism of Damage	Produces urease to neutralize acid, causing localized tissue inflammation and destruction of parietal cells².	Ferments undigested carbohydrates, producing trapped gases and causing mucosal inflammation¹.
Impact on Stomach Acid	Actively reduces stomach acid production, causing hypochlorhydria².	A downstream consequence of low stomach acid. It does not directly alter acid production².
Primary Gases Involved	Ammonia and Carbon Dioxide (used to neutralize acid)².	Hydrogen, Methane, and Hydrogen Sulfide (byproducts of fermentation)¹⁰.
Digestive Hormone Impact	Prevents the release of secretin and cholecystokinin by altering the pH of food leaving the stomach⁵.	Thrives on the undigested food left behind due to the lack of pancreatic enzymes and bile³.
Nutrient Deficiencies	Iron (failure to convert ferric to ferrous) and Vitamin B12 (failure to release from proteins)².	Iron, Vitamin B12 (bacterial consumption), and Vitamins A, D, E, K (bile acid deconjugation)¹.
Diagnostic Breath Test	Urea Breath Test (measures exhaled carbon dioxide tags)⁷.	Glucose or Lactulose Breath Test (measures exhaled hydrogen and methane)²¹.

Works Cited & Scientific References 42

▼